237 related articles for article (PubMed ID: 11724123)
1. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
Ekici S; Sahin A; Ozen H
J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
[TBL] [Abstract][Full Text] [Related]
2. [Percutaneous nephrostomy in malignant ureteral obstruction].
Demetriou D; Sebeikat D
Dtsch Med Wochenschr; 1996 Dec; 121(49):1526-30. PubMed ID: 8998920
[TBL] [Abstract][Full Text] [Related]
3. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
4. Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy.
Chiou RK; Chang WY; Horan JJ
J Urol; 1990 May; 143(5):957-9. PubMed ID: 2329611
[TBL] [Abstract][Full Text] [Related]
5. Posterior urethral valves with persistent high serum creatinine: the value of percutaneous nephrostomy.
Ghali AM; El Malki T; Sheir KZ; Ashmallah A; Mohsen T
J Urol; 2000 Oct; 164(4):1340-4. PubMed ID: 10992410
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction.
Alma E; Ercil H; Vuruskan E; Altunkol A; Unal U; Gurlen G; Goren V; Gurbuz ZG
Support Care Cancer; 2020 Nov; 28(11):5581-5588. PubMed ID: 32757161
[TBL] [Abstract][Full Text] [Related]
7. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
8. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
[TBL] [Abstract][Full Text] [Related]
9. Ureteral obstruction associated with prostate cancer: the outcome after ultrasonographic percutaneous nephrostomy.
Bordinazzo R; Benecchi L; Cazzaniga A; Vercesi A; Privitera O
Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):101-6. PubMed ID: 7889041
[TBL] [Abstract][Full Text] [Related]
10. Nonoperative urinary diversion for malignant ureteral obstruction.
Zadra JA; Jewett MA; Keresteci AG; Rankin JT; St Louis E; Grey RR; Pereira JJ
Cancer; 1987 Sep; 60(6):1353-7. PubMed ID: 3621117
[TBL] [Abstract][Full Text] [Related]
11. Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer.
Nariculam J; Murphy DG; Jenner C; Sellars N; Gwyther S; Gordon SG; Swinn MJ
Br J Radiol; 2009 Jul; 82(979):571-6. PubMed ID: 19153185
[TBL] [Abstract][Full Text] [Related]
12. The role of percutaneous nephrostomy in malignant urinary tract obstruction.
Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC
Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous nephrostomy in obstructing pelvic malignancy does not facilitate further oncological treatment.
Folkard SS; Banerjee S; Menzies-Wilson R; Reason J; Psallidas E; Clissold E; Al-Mushatat A; Chaudhri S; Green JSA
Int Urol Nephrol; 2020 Sep; 52(9):1625-1628. PubMed ID: 32319003
[TBL] [Abstract][Full Text] [Related]
14. Use of percutaneous nephrostomy in malignant ureteric obstruction.
Chapman ME; Reid JH
Br J Radiol; 1991 Apr; 64(760):318-20. PubMed ID: 2025771
[TBL] [Abstract][Full Text] [Related]
15. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
[TBL] [Abstract][Full Text] [Related]
16. Nephrostomy in patients with ureteral obstruction secondary to nonurologic malignancy. Obstructive uropathy in malignant disease.
McNamara TE; Butkus DE
Arch Intern Med; 1980 Apr; 140(4):494-7. PubMed ID: 7362379
[TBL] [Abstract][Full Text] [Related]
17. [Neoplastic ureteral obstruction: drainage by percutaneous nephrostomy or double J catheterization].
Desportes L; Blanchet P; Benoît G; Lecouturier S; Langloys J; Decaux A; Di Palma M; Richard C; Jardin A
Presse Med; 1995 Oct; 24(29):1332-6. PubMed ID: 7494843
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
[TBL] [Abstract][Full Text] [Related]
20. Improved split renal function after percutaneous nephrostomy in young adults with severe hydronephrosis due to ureteropelvic junction obstruction.
Zhang S; Zhang Q; Ji C; Zhao X; Liu G; Zhang S; Li X; Lian H; Zhang G; Guo H
J Urol; 2015 Jan; 193(1):191-5. PubMed ID: 25014578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
